The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

BACKGROUND: The management of pT1a-b pN0 HER2-positive breast cancer is controversial and no data about the efficacy of trastuzumab in this setting are available from randomized clinical trials. The aims of this retrospective study were to assess how patients are managed in clinical practice in Ital...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Gori, Stefania, Inno, Alessandro, Fiorio, Elena, Foglietta, Jennifer, Ferro, Antonella, Gulisano, Marcella, Pinotti, Graziella, Gubiotti, Marta, Cavazzini, Maria Giovanna, Turazza, Monica, Duranti, Simona, De Simone, Valeria, Iezzi, Laura, Bisagni, Giancarlo, Spazzapan, Simon, Cavanna, Luigi, Saggia, Chiara, Bria, Emilio, Cretella, Elisabetta, Vici, Patrizia, Santini, Daniele, Fabi, Alessandra, Garrone, Ornella, Frassoldati, Antonio, Amaducci, Laura, Saracchini, Silvana, Evangelisti, Lucia, Barni, Sandro, Gamucci, Teresa, Mentuccia, Lucia, Laudadio, Lucio, Zoboli, Alessandra, Marchetti, Fabiana, Bogina, Giuseppe, Lunardi, Gianluigi, Boni, Luca
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4560419/
https://ncbi.nlm.nih.gov/pubmed/26340098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0136731
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados